Track 1: Digital Pharma
Some people believe that digital capabilities are critical not only to Pharmaceutical companies' ability to improve the way they launch new products, but also to increasing the Pharmaceutical industry's contribution to health care by enabling it to provide innovative services to improve patient outcomes. To boost Pharma's perceived value inside the health care system, the industry is attempting to meet the demands of all stakeholders: health care providers, patients, and payers. Meanwhile, the culture of pharmaceutical businesses is evolving away from separate divisions functioning vertically and towards cross-functionality.
Track 2: R&D Advancement: Road to New Medicines
To deal with the innovation issue (patent loss, pipeline drying up), large pharmaceutical companies use innovative business models in order to increase their efficiency in R&D and innovation. These challenges compelled major firms to alter or reinvent their business models in order to sustain the value creation generated by R&D and innovation. However, to the best of our knowledge, there is still a dearth of understanding of the "strategic alignment" of these organisational changes and how organisational members view them.
Track 3: Clinical Pharmacy and Therapeutics
Drug absorption is determined by the chemistry, formulation, and mode of administration of the drug. Dosage forms (e.g., tablets, capsules, solutions) containing the medicine and other substances, square measure produced to be administered via various routes (e.g., oral, buccal, sublingual, rectal, parenteral, topical, inhalational). Regardless of the manner of administration, drugs should be absorbed.
Track 4: Pharmaceutical sciences
Pharmaceutical sciences encompass a wide range of scientific disciplines that are essential for the discovery and development of new medications and cures. Pharmaceutical Sciences is a dynamic and interdisciplinary field that seeks to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology in order to better understand how to deliver drugs to the body and translate this integrated understanding into new and improved therapies for human disease. Many of the institutes' internationally renowned faculty members contribute to the field by researching the underlying mechanisms of drug interactions with the human body and developing advanced synthetic or biologically derived materials that can modulate these interactions in the pursuit of better and safer therapies and drug products.
Track 5: Pharmaceutical Nanotechnology
Pharmaceutical nanotechnology is concerned with the development of novel technologies for the development of customised medication delivery systems. The drug delivery method has a favourable impact on the rate of drug absorption, distribution, metabolism, and excretion in the body. Furthermore, the drug delivery method permits the medication to connect to its target receptor and alter its signalling and activity. Pharmaceutical nanotechnology incorporates nanoscience applications to pharmacy as nanomaterials and devices such as medication delivery, diagnostic, imaging, and biosensor.
Track 6: Entrepreneurs Investment Meet
A platform that connects Entrepreneurs, Proposers, and Investors from all around the world. Its goal is to build and enable the most optimised and viable gathering place for engaging individuals in global business talks, as well as the evaluation and implementation of innovative company ideas. An investor may be able to identify the highest prospective investment possibilities worldwide that deliver a decent return on investment.
Track 7: Globalized Pharma Sector
The Globalised Pharma Sector is based on gaining information on changing competition structure and increased competitiveness, lack of brand new products despite increased investments in R&D (Research& Development) activities, increased importance of regulatory issues (registrations, intellectual property rights, litigation), fast consolidation and concentration of the world Pharmaceutical industry.
Track 8: Drug Discovery
Drug discovery is the process through which novel candidate pharmaceuticals are discovered in the domains of medicine, biotechnology, and pharmacology. The identification of screening hits, medicinal chemistry, and optimisation of those hits to boost affinity, selectivity (to limit the risk for adverse effects), efficacy or potency, metabolic stability (to increase the half-life), and oral bioavailability are all part of modern drug discovery.
Track 9: Drug Development
Once a lead molecule has been identified through the drug discovery process, drug development focuses on bringing a new pharmaceutical medicine to market. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as through the United States Food and Drug Administration for an investigational new drug to begin human clinical trials, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Track 10: Pharmaceutical Engineering
Pharmaceutical engineering is concerned with Pharmaceutical Science and Technology, which covers the creation and manufacturing of pharmaceutical products, processes, and components (i.e. medicines and biologics). While the development of pharmaceutical products requires many interconnected disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, chemists, chemical engineers, biomedical engineers, etc.), the specific subfield of "Pharmaceutical engineering" has only recently emerged as a distinct engineering discipline.
Track 11: Advances in Pharmaceutical Packaging
Packaging is critical in providing a product with protection, presentation, convenience, identity information, and compliance during storage, transportation, exhibition, and until it is safely consumed. Packaging can be thought of as a mechanism that ensures a product's safe delivery from maker to consumer. The programme focuses mostly on contemporary advancements in packaging technology and packaging materials. Many types of package labelling symbols should be domestically and internationally standardised. Product certificates, trademarks, and proof of purchase are all represented via packaging symbols.
Track 12: Purpose and Principles of GMP
The quality of medications is mostly the responsibility of manufacturers under Good Manufacturing Practises. GMP Guidelines are a technique of ensuring the quality of pharmaceuticals. The US Food and Drug Administration (FDA) enforces Current Good Manufacturing Practise (CGMP) requirements. CGMPs establish methods to ensure the proper design, monitoring, and control of manufacturing processes and facilities. Adherence to CGMP laws ensures the identity, strength, quality, and purity of drug goods by forcing medicine producers to control manufacturing activities appropriately. GMP stands for excellent common sense quality management, quality assurance, and quality control.
Track 13: Pharmaceutical Supply Chain Optimization
The integration of important business operations across the supply chain for the aim of providing value for customers and stakeholders is known as supply chain management (SCM). Supply chain management, in fact, connects supply and demand within and between businesses in an efficient business model. Supply chain management is defined by the Council of Supply Chain Management Professionals as the planning and management of all activities involved in sourcing, procurement, conversion, and all logistics activities. Eliminating bottlenecks, balancing lowest material cost and transportation, optimising manufacturing flow, maintaining the right mix and location of factories and warehouses, vehicle routing analysis, dynamic programming, and efficient use of capacities, inventories, and labours are some of the main aspects of supply chain optimisation.
Track 14: Pharmaceutical Process Validation
Pharmaceutical Process Validation is one of the most significant and well-known CGMP factors. In-process and final inspections and testing cannot adequately ensure quality, but it should be embedded into the manufacturing process. These processes must be monitored to ensure that the end product fulfils all quality standards. Validation is a key stage in achieving and maintaining final product quality. Process validation is a requirement of the quality system (QS) regulation. A quality system's goal is to continuously generate products that are fit for their intended purpose.
Track 15: Regulatory Requirements for Pharmaceuticals
There are numerous reasons for expanding merchandise development outside of mature, developed economies (e.g., the EU and thus the US), and the most of them are based on rising market population and market potential. FDA advice for clinical research and pharmaceutical development is becoming increasingly international in the direction of emerging markets that provide solutions for patient accomplishment and overall development costs and schedules.
Track 16: Medico Marketing
Medico-Marketing is concerned with the transmission of drug information between pharmaceutical companies and the recommended doctor, nurse, chemist, or end consumer. This data exchange is intended to describe the Pharmaceutical Company's goods and how they will aid the patient population in the diagnosis or management of human diseases.
Track 17: Generics versus Big Pharma
Nonetheless, throughout the last decade, most Big Pharmas have included small molecule generics in some way or another into their entire business model. And many of them publicly discuss the "innovation headroom" that a thriving low-cost generics market provides, i.e. the money saved on off-patent pharmaceuticals may be utilised to fund high-cost new ideas. They've realised they can't fight the realities of ageing populations and healthcare costs.
Track 18: Pharma and Biotech Financial Outlook
The worldwide economic slump has driven pharmaceutical and life sciences corporations to focus on cost-cutting strategies, placing financial departments under strain. Although cost reduction will always be crucial, reinvigorating R&D will almost certainly be a key strategic priority for these organisations as well. Most major pharmaceutical corporations are under competitive pressure from generic medication makers, which will intensify as additional patents for "blockbuster" drugs expire over the next few years.
Track 19: Pharmacy Education and Practice
The criteria against which we shall approve education and training for student pharmacists and pre-registration trainee pharmacists are laid forth in the standards of initial education and training for pharmacists. The requirements ensure that newly registered chemists are qualified to practise in a safe and effective manner. The mission of pharmacy education is to prepare graduates to provide patient-centered care that ensures optimal medication therapy outcomes and lays the groundwork for specialisation in specific areas of pharmacy practise; to participate in the education of patients, other health care providers, and future pharmacists; to conduct research and scholarly activity; and to provide service and leadership to the community.
Track 20: Clinical and Hospital Pharmacy
Clinical pharmacy is a branch of medicine in which chemists provide patient care that optimises pharmaceutical therapy while also promoting health and illness prevention. Clinical pharmacy conferences embrace the pharmaceutical care philosophy, combining a caring perspective with specialised therapeutic knowledge, expertise, and judgement to provide optimal patient results. Clinical pharmacy, as a specialty, is also obligated to contribute to the production of new information that enhances health and quality of life.